Pharmacia Articles

Russian Non-Rx-Bound Sales Growth To 2005

1 May 1998

P&U Sales Up, Says Turnaround Is On Track

30 April 1998

Pfizer's Viagra Already Has 95% Share Of ED Market

30 April 1998

Merck In $60 Million DTC Ads For Propecia

30 April 1998

Volvo to Sell P&U Stake

23 April 1998

Appointments At MDS Inc

23 April 1998

PowderJect's Needlefree Alprostadil

22 April 1998

Unprecedented Take-Off For Pfizer's Viagra

21 April 1998

Takeda Boosts OTC Business With J&J

17 April 1998

Changing Scene For Drugmakers In USA

14 April 1998

P&U's Detrusitol Selling Well

9 April 1998

FDA Approval News In Brief

2 April 1998

South Africa/USA Continue To Disagree On Patent Laws

1 April 1998

R-PR's Lovenox Cleared In USA For Angina

31 March 1998

Pfizer's Impotence Pill Wins FDA Clearance

31 March 1998

P&U Taken To Court Over Xanax

26 March 1998

Supreme Court Reactivates Drug Pricing Lawsuit

25 March 1998

Nycomed Amersham Pretax Profits Up 9.1% For 1997

25 March 1998

Wall Street Notes And FDA Confirms Rapid Drug Pace

23 March 1998

B-MS And UT Austin Link-Up For Telomerase Research

20 March 1998

Appointment At P&U

19 March 1998

PE Applied Biosystems Files Patent Infringement Suit

19 March 1998

Merck & Co Tops Patent Table For NCEs

18 March 1998

P&U's Detrusitol

12 March 1998

P&U To Reduce Board Of Directors

12 March 1998

EMEA CPMP Plenary Meeting In February

10 March 1998

DepoTech To File More Data On DepoCyt

9 March 1998

Pramipexole Approved In The European Union

5 March 1998

Long-Term Efficacy With Merck & Co's Proscar

5 March 1998

P&U's CEO "15% Profit Growth Too High"

26 February 1998

Capitalizing On Hair Loss Market In The UK

23 February 1998

Stock Commentary Europe

19 February 1998

Appointment at P&U

19 February 1998

P&U 1997 Sales Slide, Earnings Hit By Charges

18 February 1998

P&U Recalls Atgam Vials After CJD Scare

11 February 1998

Drug Industry Mergers: Two + Two Makes Three?

11 February 1998

Amersham Pharmacia Backs Protein Stabilization Discovery

6 February 1998

P&U Acquires Migraine Drug

5 February 1998

Trend For 1997 Strong Sales Continues In USA

5 February 1998

Stock Commentary Europe

5 February 1998

P&U Suspends Rescriptor Trial

5 February 1998

Speculation On P&U, Astra Partners

4 February 1998

Pharmacia & Upjohn/Chiron Hep C Collaboration

4 February 1998

SmithKline Beecham Jilts AHP To Wed Glaxo Wellcome To Become World Leader

2 February 1998

Strong Growth For US Drug Firms In 1997

28 January 1998

Impact Of Propecia On Merck & Co Assessed

28 January 1998

Renewed Interest In Cancer Diagnostics

23 January 1998

Stock Commentary New York

22 January 1998

Drug Cos Must Act Now To Ensure Future Prosperity

22 January 1998

DepoTech Files MAA For Savedar

22 January 1998

UK Planning Product Status Switches

21 January 1998

New Division For AXYS Pharma

21 January 1998

Appointment At R-P

15 January 1998

Appointment And Resignation At P&U

15 January 1998

P&U Licenses TPO For $35 Million

15 January 1998

SangStat To Go For New Thymoglobulin Indication

15 January 1998

Top Firms Maintaining Strong Sales & Profits

13 January 1998

Majors Moving Away From Acquisitions & Mergers

12 January 1998

CSFB Initiates Coverage Of Pharmacia & Upjohn

12 January 1998

Propecia Approved In USA For Male Pattern Baldness

12 January 1998

Majors Moving Away From Acquisitions & Mergers

6 January 1998

P&U's Edronax Cleared In Germany And Italy

6 January 1998

1997: Another Good Year For New Chemical Entities

6 January 1998

New Products In 1998; A Look Ahead

6 January 1998

P&U Launches Nicorette Inhaler

18 December 1997

P&U Concludes Sale Of Spanish Facility

18 December 1997

Patients Not Willing To Talk, Says Survey

16 December 1997

Stock Commentary Europe

11 December 1997

More Studies Needed For P&U's Halcion

11 December 1997

Massive Growth For Parkinson's Market

8 December 1997

P&U Calls Halt To Off-Label Use Of Genotropin

4 December 1997

Stock Commentary Europe

4 December 1997

AMRAD Corp Transfers Distribution Business

4 December 1997

1998 - A "Critical" Year For P&U, Says CEO

3 December 1997

Stock Commentary Europe

27 November 1997

Mexico Bans P&U For Giving False Info

27 November 1997

Appointment At P&U UK

27 November 1997

EFPIA Expands Membership To Drugmakers

24 November 1997

Stock Commentary New York

20 November 1997

IDEC Begins Ph I/II 9-AC Trial

20 November 1997

FDA C'tee Raises Concerns Over Merck's Propecia

19 November 1997

Gilead 9-Month Sales Driven By Vistide

18 November 1997

Resignation At P&U

13 November 1997

Good Performance For Nycomed And Amersham

13 November 1997

News In Brief

7 November 1997

Stock Commentary New York

7 November 1997

Axys : The Shape Of Things To Come For Biotech ?

5 November 1997

Pharmacia & Upjohn Takes $450 Million Charge

31 October 1997

Pramipexole Approved By The EMEA

23 October 1997

Will New Wave Of Antibiotics Fight Resistance?

23 October 1997

Avonex Boosts 3rd Qtr Growth At Biogen

15 October 1997

P&U Stocks Hit By Analysts' Downgrades

9 October 1997

Are There Short-Term Benefits In Mega Mergers?

9 October 1997

Fournier's Erecnos Boosted By Clinical Trial Results

8 October 1997

Synthelabo Buys P&U Unit

6 October 1997

P&U Appointment

25 September 1997

Mirapex Cuts Levodopa Reliance

25 September 1997

Growing Foreign Presence In China's Pharma Industry

22 September 1997

Stock Commentary New York

18 September 1997

First Approval For P&U's Detrusitol For Incontinence

11 September 1997

Showing 901-1000 of 1436 articles

Go to beginningPreviousNextGo to end